- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/06 - Antibacterial agents for tuberculosis
Patent holdings for IPC class A61P 31/06
Total number of patents in this class: 1322
10-year publication summary
|
49
|
49
|
54
|
80
|
82
|
83
|
72
|
67
|
99
|
71
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
45 |
| King Faisal University | 921 |
36 |
| Janssen Sciences Ireland Unlimited Company | 398 |
26 |
| Janssen Pharmaceutica N.V. | 3351 |
25 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
20 |
| Council of Scientific & Industrial Research | 1430 |
18 |
| Rutgers, The State University of New Jersey | 1933 |
14 |
| Otsuka Pharmaceutical Co., Ltd. | 1508 |
11 |
| The Global Alliance for TB Drug Development, Inc. | 42 |
10 |
| Agency for Science, Technology and Research | 3646 |
9 |
| Bioversys AG | 74 |
9 |
| Glaxo Group Limited | 4117 |
8 |
| The Johns Hopkins University | 5751 |
8 |
| Tecnimede Sociedade Tecnico-medicinal S.A. | 47 |
8 |
| The Broad Institute, Inc. | 1870 |
7 |
| Global Alliance for TB Drug Development | 9 |
7 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 182 |
7 |
| Longhorn Vaccines and Diagnostics, LLC | 90 |
7 |
| Nanyang Technological University | 2073 |
7 |
| University of Notre Dame du Lac | 581 |
7 |
| Other owners | 1033 |